The heritage of Thomas Addis: why do nephrologists still love glomerulonephritis? Giorgina Barbara Piccoli Editorial 11 May 2022 Pages: 1059 - 1060
The treatment of membranous nephropathy: a journey in the search for evidence Lucia Del VecchioFrancesco LocatelliClaudio Ponticelli Commentary 01 March 2022 Pages: 1061 - 1063
Extrarenal complications of granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA) and their impact on the outcome of the patients Vladimir TesarZdenka Hruskova Commentary 24 February 2022 Pages: 1065 - 1068
Urinary exosomal circular RNAs of sex chromosome origin are associated with gender-related risk differences of clinicopathological features in patients with IgA nephropathy Rumei LuanGeng TianXuehong Lu Original Article 22 July 2021 Pages: 1069 - 1078
The effect of immunosuppressive therapy in patients with fibrinoid necrosis lesions in a large cohort of patients with IgA nephropathy Yingman GuoSufang ShiHong Zhang original Article 21 October 2021 Pages: 1079 - 1089
IgA nephropathy and atypical hemolytic uremic syndrome: a case series and a literature review Lucio ManentiGiovanni Maria RossiEnrico Fiaccadori original Article 10 November 2021 Pages: 1091 - 1100
Oxidative stress and macrophage infiltration in IgA nephropathy Yasar CaliskanErol DemirHalil Yazici Original Article 16 November 2021 Pages: 1101 - 1111
Clinicopathological characteristics, risk factors and renal outcome in IgA nephropathy with crescents Yiping RuanFuyuan HongQiaoyun Huang original Article 15 March 2022 Pages: 1113 - 1121
Long-term health-related quality of life outcomes of adults with pediatric onset of frequently relapsing or steroid-dependent nephrotic syndrome Marie-Sophie MeulemanSophie Guilmin-CréponHélène Mellerio Original Article 05 July 2021 Pages: 1123 - 1134
Time to remission of proteinuria and incidence of relapse in patients with steroid-sensitive minimal change disease and focal segmental glomerulosclerosis: the Japan Nephrotic Syndrome Cohort Study Ryohei YamamotoEnyu Imaithe Japan Nephrotic Syndrome Cohort Study investigators original Article 02 April 2022 Pages: 1135 - 1144
Effects of hydroxychloroquine on proteinuria in membranous nephropathy Yan-jiao ChengXu-yang ChengMing-hui Zhao original Article 30 November 2021 Pages: 1145 - 1157
Immunosuppression therapy for idiopathic membranous nephropathy: systematic review with network meta-analysis Bhadran BoseEdmund Y. M. ChungSuetonia C. Palmer original Article Open access 23 February 2022 Pages: 1159 - 1170
Characterization of interstitial infiltrates in MPO and PR3 anti-neutrophil cytoplasmic antibody glomerulonephritis Sam Kant Lois J. Arend Duvuru Geetha Original Article 20 July 2021 Pages: 1171 - 1175
Neutrophils associate with Bowman’s capsule rupture specifically in PR3-ANCA glomerulonephritis Samy HakroushBjörn Tampe original Article Open access 01 December 2021 Pages: 1177 - 1183
Prevalence of ANCA-associated vasculitis amid natural gas drilling sites in West Virginia Devan MakatiJames AkersDinesh Kannabhiran original Article 06 January 2022 Pages: 1185 - 1192
Association of Bowman’s capsule rupture with prognosis in patients with lupus nephritis Tongyue DuanXuejing ZhuLin Sun original Article 18 April 2022 Pages: 1193 - 1204
Eculizumab treatment in atypical hemolytic uremic syndrome: correlation between functional complement tests and drug levels Massimo CugnoValentina CaponeGianluigi Ardissino original Article 11 January 2022 Pages: 1205 - 1211
Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study Esra BaskinKibriya FidanOguz Soylemezoglu Original Article 21 January 2022 Pages: 1213 - 1222
Clinical features and prognostic factors of acute kidney injury caused by adult secondary hemophagocytic lymphohistiocytosis Siwen WangJiaojiao ZhouLichuan Yang Original Article 21 January 2022 Pages: 1223 - 1233
Identification of glomerulosclerosis using IBM Watson and shallow neural networks Francesco PesceFederica AlbaneseLoreto Gesualdo original Article 18 January 2022 Pages: 1235 - 1242
Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion Stefano MurgiaGiacomo QuattrocchioDario Roccatello Original Article 04 January 2022 Pages: 1243 - 1249
pANCA autoantibody testing by indirect immunofluorescence indicates interstitial arteritis independent of MPO-ANCA immunoassays in ANCA-associated glomerulonephritis Samy HakroushIngmar Alexander KlugeBjörn Tampe Research Letter Open access 05 April 2022 Pages: 1251 - 1254
Eculizumab in low-middle income countries: how much does a life cost? Hong Si NgaLilian Monteiro Pereira PalmaLuis Gustavo Modelli de Andrade From Distant Places 02 April 2022 Pages: 1255 - 1257
Histopathological and ultrastructural monitoring of remission induction in crescentic C3 glomerulonephritis Samy HakroushAnn-Kathrin GersmannBjörn Tampe Lessons for the Clinical Nephrologist 06 November 2021 Pages: 1259 - 1263
Filgrastim-induced recurrent macroscopic hematuria in a patient with DNAJB9 positive fibrillary glomerulonephritis Anne-Laure FauconSophie CerejaValérie Caudwell Lessons for the Clinical Nephrologist 24 February 2022 Pages: 1265 - 1270
Thrombotic microangiopathy with mild renal involvement and profound thrombocytopenia: not all roads lead to thrombotic thrombocytopenic purpura Victor MilonNicolas FageBenoit Brilland Lessons for the Clinical Nephrologist 22 March 2022 Pages: 1271 - 1273
Everolimus-associated alveolar hemorrage relapse after drug discontinuation in a kidney transplant recipient Marco BusuttiAlessandra CingolaniGaetano La Manna Lessons for the Clinical Nephrologist 14 March 2022 Pages: 1275 - 1278
Collapsing focal segmental glomerulosclerosis successfully treated with combination of steroid pulse and low-density lipoprotein apheresis: lessons for the clinical nephrologist Yoshitaka FurutoHirotsugu HashimotoYuko Shibuya Case Report 30 November 2021 Pages: 1279 - 1282
Kinetics of human leukocyte antigen receptor HLA-DR+ monocytes and T lymphocytes during remission induction therapy in ANCA-associated vasculitis Désirée TampeSamy HakroushBjörn Tampe Case Report Open access 21 April 2022 Pages: 1283 - 1287
Treatment with bortezomib for recurrent proliferative glomerulonephritis with monoclonal IgG deposits in kidney allograft. Case report and review of the literature Rikako OkiKohei UnagamiHideki Ishida Case Report Open access 06 May 2022 Pages: 1289 - 1293
Renal involvement of intravascular large B-cell lymphoma: a challenging diagnosis Samy HakroushLuca-Yves LehnigMichael Johann Koziolek Art in the Ward 06 July 2021 Pages: 1295 - 1297
Nephrology pictures: pemphigus vulgaris and membranous nephropathy Gisele VajgelMatheus R. B. CorreiaLuis H. Sette Art in the Ward 15 October 2021 Pages: 1299 - 1301
Acute kidney injury in a man with chronic myelomonocytic leukemia Chien-Yao SunChing-Chun LinYu-Tzu Chang Art in the Ward 07 October 2021 Pages: 1303 - 1304
Shared decision-making and disclosure of adverse events: critical aspects for the quality and safety of kidney transplant practice Alessandra Agnese GrossiTullia Maria De FeoMario Picozzi Art in the Ward 16 November 2021 Pages: 1305 - 1307
Correction to: Eculizumab treatment and discontinuation in pediatric patients with atypical hemolytic uremic syndrome: a multicentric retrospective study Esra BaskinKibriya FidanOguz Soylemezoglu Correction 07 February 2022 Pages: 1309 - 1309
